Androgen Receptor Blocking Peptide peptide (Phospho) (STJ505895) STJ505895-250 上海玉博生物科技有限公司

Androgen Receptor Blocking Peptide peptide (Phospho) (STJ505895)

如果您对该产品感兴趣的话，可以
产品名称：Androgen Receptor Blocking Peptide peptide (Phospho) (STJ505895)
产品型号：STJ505895-250
产品展商：ST john's laboratory
产品文档：无相关文档

简单介绍

Androgen Receptor Blocking Peptide peptide (Phospho) (STJ505895)

产品描述

Applications:	Immunodepletion/Immunocompetition
Note:	STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description:	Phospho-Androgen Receptor Blocking Peptide is synthetically produced from the 550-600 sequence and is suitable for use in western blot applications.

Storage Instruction:

Store at-20°C for long term storage. Avoid freeze-thaw cycles.

Gene Symbol:	AR
Gene ID:	367
Uniprot ID:	ANDR_HUMAN
Immunogen Region:	550-600
Immunogen:	Synthetic peptide corresponding to amino acids within region 550-600 on Human Androgen Receptor. Phospho Serine 568.

Post Translational Modifications	Sumoylated on Lys-388 (major) and Lys-521. Ubiquitinated. Deubiquitinated by USP26. 'Lys-6' and 'Lys-27'-linked polyubiquitination by RNF6 modulates AR transcriptional activity and specificity. Phosphorylated in prostate cancer cells in response to several growth factors including EGF. Phosphorylation is induced by c-Src kinase (CSK). Tyr-535 is one of the major phosphorylation sites and an increase in phosphorylation and Src kinase activity is associated with prostate cancer progression. Phosphorylation by TNK2 enhances the DNA-binding and transcriptional activity and may be responsible for androgen-independent progression of prostate cancer. Phosphorylation at Ser-83 by CDK9 regulates AR promoter selectivity and cell growth. Phosphorylation by PAK6 leads to AR-mediated transcription inhibition. Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is required for plasma membrane targeting and for rapid intracellular signaling via ERK and AKT kinases and cAMP generation.
Function	Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins like ZBTB7A that recruits NCOR1 and NCOR2 to the androgen response elements/ARE on target genes, negatively regulating androgen receptor signaling and androgen-induced cell proliferation. Transcription activation is also down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3. Isoform 3: Lacks the C-terminal ligand-binding domain and may therefore constitutively activate the transcription of a specific set of genes independently of steroid hormones. Isoform 4: Lacks the C-terminal ligand-binding domain and may therefore constitutively activate the transcription of a specific set of genes independently of steroid hormones.
Peptide Name	Androgen Receptor Dihydrotestosterone Receptor Nuclear Receptor Subfamily 3 Group C Member 4
Database Links	Reactome: R-HSA-3371497 Reactome: R-HSA-383280 Reactome: R-HSA-4090294 Reactome: R-HSA-5625886 Reactome: R-HSA-5689880 Reactome: R-HSA-8940973
Cellular Localisation	Nucleus Cytoplasm Detected At The Promoter Of Target Genes Predominantly Cytoplasmic In Unligated Form But Translocates To The Nucleus Upon Ligand-Binding Can Also Translocate To The Nucleus In Unligated Form In The Presence Of Rack1
Alternative Peptide Names	Androgen Receptor protein Dihydrotestosterone Receptor protein Nuclear Receptor Subfamily 3 Group C Member 4 protein AR protein DHTR protein NR3C4 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance

产品留言

标题

联系人

联系电话

内容

验证码

点击换一张

注：1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!

温馨提示：为规避购买风险，建议您在购买前务必确认供应商资质与产品质量。
免责申明：以上内容为注册会员自行发布，若信息的真实性、合法性存在争议，平台将会监督协助处理，欢迎举报

产品目录

产品资料

Androgen Receptor Blocking Peptide peptide (Phospho) (STJ505895)